PEG-Coated Nanoparticles for Brain Interstitium Distribution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nanoparticle delivery methods, such as convection-enhanced delivery, face challenges in achieving widespread distribution in the brain interstitium due to barriers imposed by the extracellular matrix and perivascular spaces, leading to sub-optimal therapeutic concentrations and reduced efficacy in treating neurological diseases.
Innovation Solution
Development of nanoparticles coated with a dense layer of polyethylene glycol (PEG) and administered in a hyperosmolar solution, which reduces adhesion with the brain extracellular matrix and increases pore sizes, facilitating enhanced diffusion and escape from perivascular spaces into the brain interstitium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Volume of moving object
If conventional nanoparticles are administered via convection-enhanced delivery, then the delivery method can circumvent the blood brain barrier, but the nanoparticles fail to achieve widespread distribution in the brain interstitium due to barriers imposed by the extracellular matrix and perivascular spaces
Solution Approach 1:
The patent changes the physical-chemical parameters of the nanoparticle surface by coating with PEG, transforming the surface properties to reduce adhesive interactions with the extracellular matrix. This parameter change enables the nanoparticles to overcome the harmful barriers and achieve widespread distribution in the brain interstitium
Solution Approach 2:
The PEG coating acts as an intermediary layer between the nanoparticle core and the extracellular matrix, preventing direct adhesive interactions. This mediator layer allows the nanoparticles to navigate through the brain tissue without being trapped by the matrix barriers
2Speed
If nanoparticles are confined within perivascular spaces, then they can travel through low resistance fluid-filled spaces, but their ability to reach target cells in the brain interstitium is reduced
Solution Approach 1:
The PEG coating changes the surface parameters of the nanoparticles, enabling them to transition from being confined to perivascular spaces to actively entering and distributing throughout the brain interstitium. This parameter change ensures both efficient transport and reliable target cell delivery
3Force
If the extracellular matrix components interact with conventional nanoparticles, then adhesion occurs, but this adhesion sterically hinders nanoparticle diffusion within the brain interstitium
Solution Approach 1:
The patent converts the harmful adhesive interaction into a beneficial non-adhesive state by PEG coating. The PEG layer prevents unwanted adhesion to the extracellular matrix, thereby eliminating the steric hindrance and enabling rapid diffusion of nanoparticles through the brain interstitium
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The PEG-coated nanoparticles achieve significantly higher volume of distribution and diffusion within the brain interstitium, overcoming adhesive interactions and steric hindrances, thereby improving therapeutic delivery and efficacy for neurological disorders.
Implementation Method 1
reduces adhesion with the brain extracellular matrix
Implementation Method 2
administered in ahyperosmolar solution, which reduces adhesion with the brain extracellular matrix and increases pore sizes
Data Source
AI summary
Improved distribution can be achieved by delivering nanoparticles possessing non-adhesive surfaces via CED in a hyperosmolar infusate solution. This delivery strategy minimizes the hindrances imposed by the brain extracellular matrix and reduces the concentration of therapeutic that is confined within perivascular spaces.